A Patient Power Team Member's Clinical Trial Video Diary: Month Two

Patient Power contributor Michele Nadeem, on location at the Dana-Faber Cancer Institute, shares a video health update as she enters month two of the clinical trial she is participating in, which combines ibrutinib (Imbuvica) with FCR (fludarabine, cyclophosphamide, rituximab). Michele reviews the side effects she has experienced since beginning the trial and why she feels the progress she has seen is “truly a miracle.”